DRF-1042 is an orally active camptothecin derivative that inhibits DNA topoisomerase I. It exhibits strong anticancer activity against various human cancer cell lines, including those with multi-drug resistance (MDR), and has cytotoxic effects.
Products > ADC Linker, ADC Payload > ADC Payload | Products > ADC Linker, ADC Payload > ADC Payload > Camptothecin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye